Skip to main content



) --




) hit a new 52-week high Friday as it is currently trading at $93.88, above its previous 52-week high of $93.46 with 66,064 shares traded as of 9:35 a.m. ET. Average volume has been 1.9 million shares over the past 30 days.

McKesson has a market cap of $21.8 billion and is part of the


sector and


industry. Shares are up 18.5% year to date as of the close of trading on Thursday.

TheStreet Recommends

McKesson Corporation delivers medicines, pharmaceutical supplies, information, and care management products and services for the healthcare industry. The company has a P/E ratio of 16.5, equal to the average wholesale industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

TheStreet Ratings rates McKesson as a


. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full

McKesson Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center